Pfizer (NYSE: PFE) announced a strategic license agreement with Chai Discovery, an artificial intelligence company...
Biogen (NASDAQ: BIIB) announced it has received Breakthrough Therapy Designation (BTD) from the U.S. Food...
Innovent Biologics (HKG: 1801) announced that the pre-specified first interim analysis from the global Phase...
Everest Medicines (HKG: 1952) announced a licensing agreement with fellow Chinese biopharmaceutical company Beijing Mabworks...
Jiangsu Vcare PharmaTech Co., Ltd. announced that China’s National Medical Products Administration (NMPA) has granted...
GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food...
Hansoh Pharmaceutical Group Co., Ltd. (HKG: 3692) announced that China’s National Medical Products Administration (NMPA)...
Johnson & Johnson (J&J, NYSE: JNJ) announced positive results from the Phase II JASMINE study...
H. Lundbeck A/S (OTCMKTS: HLUBF) announced on June 3, 2026, a strategic partnership with Cradle,...
Novo Nordisk A/S (NYSE: NVO) announced the market launch of Wegovy (semaglutide) oral tablets in...
Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has significantly expanded its collaboration with fellow US biotechnology company...
Ascidian Therapeutics, a US-based biotechnology company pioneering RNA exon editing technology, announced a global research...
Medtronic plc (NYSE: MDT) announced on June 3, 2026, the submission of 510(k) premarket notifications...
Yunnan Baiyao Group Co., Ltd. (SHE: 000538), a leading traditional Chinese medicine (TCM) company, announced...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced it has received clinical...
Medtronic plc (NYSE: MDT) announced financial results for its fourth quarter (Q4) and fiscal year...
The U.S. Food and Drug Administration (FDA) released draft guidance on June 2, 2026, designed...
China’s National Health Commission (NHC) has released the “Notice on Further Improving the Urban Community...
Shandong Boan Biotechnology Co., Ltd. (HKG: 6955) announced a licensing agreement with an undisclosed pharmaceutical...